Circulatives Dementia
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Pharmaceuticals
Yuyu Pharma., Inc.
- Country / Year Established
- South Korea /
- Business type
- Others
- Verified Certificate
-
16
Product name | Circulatives Dementia | Certification | - |
---|---|---|---|
Category | Pharmaceuticals | Ingredients | - |
Keyword | - | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | Stock | - | |
Supply type | - | HS code | - |
Product Information
Tanamina tablet strongly inhibits PAF(Platelet Activating Factor) which promotes platelet aggregation, and thus, it improves cerebral and peripheral circulation by anti-thrombotic action, inhibition of angioedema and improvement of blood circulation.
Dosage & Administration
- Tab. 40mg. Adults :
For organic disorders of cerebral function(dementia) : as ginkgo biloba extract, take 1 -2 tablets (40-80mg)three times a day.
For dizziness, tinnitus, circulatory disorders of peripheral arteries : as ginkgo biloba extract, take 1 tablet (40mg)three times a day or take 2 tablets(80mg) twice a day.
Dosage may be increased and/or depending on age and symptoms of patient. - Tab. 80mg. Adults :
For organic disorders of cerebral function(dementia) : as ginkgo biloba extract, take 1 tablets (80mg) two or three times a day. For dizziness, tinnitus, circulatory disorders of peripheral arteries : as ginkgo biloba extract, take 1 tablet (80mg) twice a day.
Dosage may be increased and/or depending on age and symptoms of patient.
Packing units
- 40mg : 200, 500T
- 80mg : 60, 500T
Composition
- Tab. 40mg : Each tablet contains, Ginkgo biloba extract....... 40.0mg (as total Ginkgo flavone glycosides 9.6mg)
- Tab. 80mg : Each tablet contains, Ginkgo biloba extract....... 80.0mg (as total Ginkgo flavone glycosides 19.2mg)
- Soft Cap. 40mg : Each capsule contains, Ginkgo biloba extract.... 40.0mg (as total Ginkgo flavone glycosides 9.6mg)
Indications
- For the treatment of organic disorders of cerebral function accompanying with demential symptoms such as memory loss, disturbance of concentration, depressive mood, dizziness, tinnitus, and headache
- Dizziness, vascular and/or demential tinnitus
- Treatment for circulatory disorders of peripheral arteries(intermittent claudication)
Features
- PAF Antagonism
Tanamina tablet strongly inhibits PAF(Platelet Activating Factor) which promotes platelet aggregation, and thus, it improves cerebral and peripheral circulation by anti-thrombotic action, inhibition of angioedema and improvement of blood circulation. - Free Radical Scavenging Properties
Tanamina tablet strongly scavenges and removes free radical, so it improves damage on cell membrane and symptoms of circulatory disorders especially caused by damage on blood vessels and neuron. - Influence on the Energy Metabolism
Tanamina tablet increases glucose utilization even under ischemic condition, so it prevents cerebral cell damage caused by disorders in energy metabolism
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Seung Pil, Yu
- Address
- Yuyu Bldg., 197, Dongho-ro, Jung-gu, Seoul, Korea
- Product Category
- Herbal Medicine,Pharmaceuticals
- No. of Total Employees
- 101-500
- Company introduction
-
Yuyu Pharma., Inc. is one of the leading innovators and marketers of pharmaceutical products with over 250 employees nationwide in Korea.
Yuyu's mission is to improve the quality life by providing the most effective and safe medical treatments in the market.The company has kept this promise since its establishment in 1941 and will continue to do so with the introduction of new generation of medicines.
Recently, Yuyu has begun to focus more on how to serve the aging population, as people are living longer and searching for ways to live a ealthier life. This has led us to be a specialist in the fields of degenerative neurological disease, osteoporosis and cerebrovascular diseases. Yuyu's treatment in these three areas has proven to be fruitful and we will continue to focus in these therapeutic categories.In order to increase out area of expertise, we also have plans to further expand out presence in the field of gastrointestinal diseasea and antibiotics.
- Main Product
Related Products
ANACELL - Alopecia prevention solution approved by the Ministry of Food and Drug Safety in Korea
Sentrip Oral Dissolving Film 10mg/20mg(TADALAFIL 20mg)
Botalinum Ampoule
Drug, medicine, API, pharmaceutical raw material, surgical dressing
Korea Red Ginseng extract(Plus)